Related Experiment Video
Updated: Mar 11, 2026

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
Glucocorticoid Signaling and Bone Biology
1Department of Cell Biology, Unit of Basic Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Glucocorticoids, while treating diseases, cause osteoporosis by harming bone cells and disrupting bone remodeling. This review explores their complex effects on bone formation and resorption, impacting patient fracture risk.
Area of Science:
- Bone Biology
- Endocrinology
- Pharmacology
Background:
- Glucocorticoids are vital for treating inflammatory and autoimmune diseases.
- Glucocorticoid-induced osteoporosis is a common secondary form, leading to fractures in 30-50% of patients on chronic therapy.
- Physiologically, glucocorticoids regulate osteoblast differentiation via pathways like Wnt/β-catenin, but excess levels negatively impact bone health.
Purpose of the Study:
- To review the mechanisms by which excess glucocorticoids induce osteoporosis.
- To elucidate the effects of glucocorticoids on osteoblast and osteocyte survival, bone formation, and bone resorption.
- To discuss the role of molecular pathways, including Wnt/β-catenin and microRNAs, in glucocorticoid-induced bone loss.
Main Methods:
- Review of existing literature on glucocorticoid effects on bone metabolism.
- Analysis of molecular mechanisms underlying glucocorticoid-induced apoptosis and impaired osteoblastogenesis.
- Examination of glucocorticoid impact on bone resorption pathways and osteoclast function.
Main Results:
- Excess glucocorticoids induce osteoblast and osteocyte apoptosis via increased pro-apoptotic molecules, reactive oxygen species, and endoplasmic reticulum stress, while suppressing the Wnt/β-catenin pathway.
- Glucocorticoids impair osteoblastogenesis by inducing Wnt antagonists and reducing β-catenin phosphorylation.
- Glucocorticoids enhance bone resorption by altering OPG/Rankl expression and reactive oxygen species, yet paradoxically suppress osteoclast bone-degrading capacity.
Conclusions:
- Excess glucocorticoids disrupt bone homeostasis by promoting osteoblast apoptosis, inhibiting bone formation, and modulating bone resorption.
- Molecular pathways including Wnt/β-catenin signaling, microRNAs, and autophagy play critical roles in glucocorticoid-induced bone loss.
- Understanding these mechanisms is crucial for developing strategies to prevent or treat glucocorticoid-induced osteoporosis and mitigate fracture risk.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
TGF - β Signaling Pathway
Bone Remodeling
Endocrine Signaling
The JAK-STAT Signaling Pathway

